April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 07, 2026
The mechanobiology-centered therapy market is expanding due to growing mechanosensitive treatment approaches as well as rising mechanobiology research. North America led the market due to the presence of well-developed industries....
January 07, 2026
Projections indicate that, the LV-based cell and gene therapy products market was valued at USD 5.48 billion in 2025 and is projected to grow from USD 6.42 billion in 2026 to approximately USD 26.94 billion by 2035, expanding at a CAGR of 17.27% during the forecast period. This report provides in-depth coverage of market size, historical and foreca...
January 06, 2026
Based on market forecasts, the global hair transplant market, projected at USD 8.87 billion in 2025, is expected to reach USD 59.89 billion by 2035, growing at a CAGR of 21.04% over the forecast period. In 2024, North America led the hair transplant market, with Asia Pacific projected to grow the fastest. The FUE technique dominated, and males led ...
January 05, 2026
Based on market forecasts, the collagen fillers market was valued at USD 53.22 million in 2025 and is projected to grow from USD 56.65 million in 2026 to USD 99.34 million by 2035, registering a CAGR of 6.44% during the forecast period. The report provides in-depth coverage of market size, segment-wise analysis, regional performance across North Am...
January 02, 2026
Market insights predict the global parenteral antibiotics industry will increase from USD 25.3 billion in 2025 to USD 38.7 billion by 2035, achieving a CAGR of 4.34%. The huge preference for parenteral antibiotics is driven by malabsorption issues, lack of oral formulations, and failed oral therapy....